XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Feb. 13, 2024
Feb. 06, 2024
Feb. 05, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants exercisable               3,351,580
Proceeds from issuance of warrants           $ 2,189,420    
Issuance costs           $ 595,364    
Shares held in abeyance       1,201,580   1,201,580   1,201,580
Stock issued during period value new issues         $ 411,710      
Gain on exchange of warrants       $ 1,711,698  
Warrants exercisable and outstanding       $ 0   $ 0    
Stock options granted       0 0 1,934,716    
Equity Option [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Grant options shares $ 2,140,000              
Weighted average grant date fair value of stock options granted           $ 1.11 $ 2.77  
Equity Option [Member] | Monthly Over One Year [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Purchase of common shares 513,663              
Equity Option [Member] | Quarterly Over Two Years [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Purchase of common shares 1,421,053              
Purchase of common shares 50.00%              
Employees [Member] | Equity Option [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Purchase of common shares 1,934,716              
Exercise price $ 1.45              
Existing Warrants [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants exercisable   3,351,580   3,351,580   3,351,580    
New Warrants [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Exercise price   $ 2.33            
Proceeds from issuance of warrants   $ 8,100,000       $ 314,211    
Issuance costs   $ 595,364            
New Warrants [Member] | Investor [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Issuance costs           595,364    
Stock issued during period value warrants           2,189,420    
Gain on exchange of warrants           $ 1,711,698    
New Warrants [Member] | Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants exercisable   2,513,686            
Exercise price   $ 2.43            
Warrants for cash and the payment   $ 0.125            
Common Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrants exercisable       2,150,000   2,150,000   2,150,000
Stock issued during period shares new issues         93,551      
Stock issued during period value new issues         $ 9      
Warrant [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Shares held in abeyance   1,201,580            
Warrant [Member] | Roth Capital Partners LLC [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Issuance costs     $ 528,000     $ 595,364    
Existing Warrant [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Proceeds from issuance of warrants           7,809,181    
Existing Warrant [Member] | Investor [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Proceeds from issuance of warrants           8,123,392    
Fair value of adjustment           $ 1,115,334    
Stock issued during period shares new issues           3,351,580    
Stock issued during period value new issues           $ 4,742,244